What's more, Novo Nordisk's weight loss drug has relieved the "horrible arthritis in my knees" and made her feel "much, much better," she said. But beginning Jan. 1, Halstead's federal Blue Cross Blue Shield health insurance plan is changing coverage for glucagon-like peptide 1 drugs such as Wegovy and Ozempic. The drug she now gets for $25 per month will skyrocket to…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Health insurance marketplace enrollment underway
Semi Annual Report by Investment Company (Form N CSRS)
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News